Nicola K Wills1,2,3, David S Lawrence2,4, Elizabeth Botsile5, Mark W Tenforde6,7, Joseph N Jarvis2,4. 1. Welcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa. 2. Department of Clinical Research, Faculty of infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. 3. Department of Medicine, Groote Schuur Hospital University of Cape Town, Cape Town, 7925, South Africa. 4. Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana. 5. Department of Medicine, Princess Marina Hospital, Gaborone, Botswana. 6. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA. 7. Department of Epidemiology, University of Washington School of Public Health, Seattle, 98195, WA, USA.
Abstract
BACKGROUND: The epidemiology of Pneumocystis jirovecii, known to colonize the respiratory tract and cause a life-threatening HIV-associated pneumonia (PCP), is poorly described in Africa. We conducted a systematic review to evaluate P. jirovecii prevalence in African HIV-positive adults with or without respiratory symptoms. METHODS: We searched Medline, Embase, Cochrane library, Africa-Wide, and Web of Science for studies employing PCR and/or microscopy for P. jirovecii detection in respiratory samples from HIV-positive adults in Africa between 1995 and 2020. Prevalence with respiratory symptoms was pooled using random-effect meta-analysis, and stratified by laboratory method, sample tested, study setting, CD4 count, and trimethoprim/sulfamethoxazole prophylaxis. Colonization prevalence in asymptomatic adults and in adults with non-PCP respiratory disease was described, and quantitative PCR (qPCR) thresholds to distinguish colonization from microscopy-confirmed PCP reviewed. RESULTS: Thirty-two studies were included, with 27 studies (87%) at high risk of selection bias. P. jirovecii was detected in 19% [95% confidence interval (CI): 12-27%] of 3583 symptomatic and in 9% [95% CI: 0-45%] of 140 asymptomatic adults. Among symptomatic adults, prevalence was 22% [95% CI: 12-35%] by PCR and 15% [95% CI: 9-23%] by microscopy. Seven percent of 435 symptomatic adults had PCR-detected Pneumocystis colonization without evidence of PCP [95% CI: 5-10%, four studies]. One study established a qPCR cutoff of 78 copies/5μl of DNA in 305 induced sputum samples to distinguish Pneumocystis colonization from microscopy-confirmed PCP. CONCLUSION: Despite widened access to HIV services, P. jirovecii remains common in Africa. Prevalence estimates and qPCR-based definitions of colonization are limited, and overall quality of studies is low.
BACKGROUND: The epidemiology of Pneumocystis jirovecii, known to colonize the respiratory tract and cause a life-threatening HIV-associated pneumonia (PCP), is poorly described in Africa. We conducted a systematic review to evaluate P. jirovecii prevalence in African HIV-positive adults with or without respiratory symptoms. METHODS: We searched Medline, Embase, Cochrane library, Africa-Wide, and Web of Science for studies employing PCR and/or microscopy for P. jirovecii detection in respiratory samples from HIV-positive adults in Africa between 1995 and 2020. Prevalence with respiratory symptoms was pooled using random-effect meta-analysis, and stratified by laboratory method, sample tested, study setting, CD4 count, and trimethoprim/sulfamethoxazole prophylaxis. Colonization prevalence in asymptomatic adults and in adults with non-PCP respiratory disease was described, and quantitative PCR (qPCR) thresholds to distinguish colonization from microscopy-confirmed PCP reviewed. RESULTS: Thirty-two studies were included, with 27 studies (87%) at high risk of selection bias. P. jirovecii was detected in 19% [95% confidence interval (CI): 12-27%] of 3583 symptomatic and in 9% [95% CI: 0-45%] of 140 asymptomatic adults. Among symptomatic adults, prevalence was 22% [95% CI: 12-35%] by PCR and 15% [95% CI: 9-23%] by microscopy. Seven percent of 435 symptomatic adults had PCR-detected Pneumocystis colonization without evidence of PCP [95% CI: 5-10%, four studies]. One study established a qPCR cutoff of 78 copies/5μl of DNA in 305 induced sputum samples to distinguish Pneumocystis colonization from microscopy-confirmed PCP. CONCLUSION: Despite widened access to HIV services, P. jirovecii remains common in Africa. Prevalence estimates and qPCR-based definitions of colonization are limited, and overall quality of studies is low.
Authors: Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman Journal: J Thorac Dis Date: 2017-06 Impact factor: 2.895
Authors: M Rabodonirina; D Raffenot; L Cotte; A Boibieux; M Mayençon; G Bayle; F Persat; F Rabatel; C Trepo; D Peyramond; M A Piens Journal: J Clin Microbiol Date: 1997-11 Impact factor: 5.948
Authors: A G Smulian; D W Sullivan; M J Linke; N A Halsey; T C Quinn; A P MacPhail; M A Hernandez-Avila; S T Hong; P D Walzer Journal: J Infect Dis Date: 1993-05 Impact factor: 5.226
Authors: Lotte Jensen; Andreas V Jensen; George Praygod; Jeremiah Kidola; Daniel Faurholt-Jepsen; John Changalucha; Nyagosya Range; Henrik Friis; Jannik Helweg-Larsen; Jorgen S Jensen; Aase B Andersen Journal: BMC Infect Dis Date: 2010-05-28 Impact factor: 3.090
Authors: Menard L Chihana; Helena Huerga; Gilles Van Cutsem; Tom Ellman; Eric Goemaere; Stephen Wanjala; Charlie Masiku; Elisabeth Szumilin; Jean-Francois Etard; David Maman; Mary-Ann Davies Journal: Glob Health Action Date: 2019 Impact factor: 2.640
Authors: Emily G McDonald; Guillaume Butler-Laporte; Olivier Del Corpo; Jimmy M Hsu; Alexander Lawandi; Julien Senecal; Zahra N Sohani; Matthew P Cheng; Todd C Lee Journal: Open Forum Infect Dis Date: 2021-10-29 Impact factor: 3.835